Sponsor Pipeline

Biomea Fusion Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
5
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-08 NCT07502495
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving…		 date change Primary completion moved earlier: 2027-06 -> 2027-03
2026-08-08 NCT07502495
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving…		 date change Completion pushed: 2027-07 -> 2027-09
Active Trials by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07502508 Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not… Type 2 Diabetes Recruiting
NCT07502495 Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving… Type 2 Diabetes Recruiting
Phase 1
NCT05918692 A Phase 1 Study of BMF-500 in Adults With Acute Leukemia Acute Myeloid Leukemia Active, Not Recruiting
NCT07223216 Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants Obesity Active, Not Recruiting
Disease Areas
Type 2 Diabetes (2) Diabetes (2) Leukemia (1) Acute Myeloid Leukemia (AML) (1) Obesity (1)
Get alerts when Biomea Fusion Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free